These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18936912)

  • 1. A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.
    Matafome P; Nunes E; Louro T; Amaral C; Crisóstomo J; Rodrigues L; Moedas AR; Monteiro P; Cipriano A; Seiça R
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):241-51. PubMed ID: 18936912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic association of atorvastatin and insulin in cardiac ischemia: study in a model of type 2 diabetes with hyperlipidemia.
    Matafome P; Monteiro P; Nunes E; Louro T; Amaral C; Moedas AR; Gonçalves L; Providência L; Seiça R
    Pharmacol Res; 2008; 58(3-4):208-14. PubMed ID: 18692137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia.
    Matafome P; Louro T; Rodrigues L; Crisóstomo J; Nunes E; Amaral C; Monteiro P; Cipriano A; Seiça R
    Diabetes Metab Res Rev; 2011 Jan; 27(1):54-62. PubMed ID: 21218508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin-mediated protection of the retina in a model of diabetes with hyperlipidemia.
    Fernandes R; Bento CF; Matafome P; Sena CM; Seiça RM; Pereira P
    Can J Physiol Pharmacol; 2014 Dec; 92(12):1037-43. PubMed ID: 25404034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of atorvastatin and insulin in vascular dysfunction associated with type 2 diabetes.
    Sena CM; Matafome P; Louro T; Nunes E; Seiça RM
    Physiol Res; 2014; 63(2):189-97. PubMed ID: 24397805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats.
    Ji G; Zhao X; Leng L; Liu P; Jiang Z
    Lipids Health Dis; 2011 Jan; 10():23. PubMed ID: 21269482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an experimental diet model in rats to study hyperlipidemia and insulin resistance, markers for coronary heart disease.
    Munshi RP; Joshi SG; Rane BN
    Indian J Pharmacol; 2014; 46(3):270-6. PubMed ID: 24987172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats.
    Polce SA; Burke C; França LM; Kramer B; de Andrade Paes AM; Carrillo-Sepulveda MA
    Nutrients; 2018 Apr; 10(5):. PubMed ID: 29693586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
    Chu CS; Lee KT; Lee MY; Su HM; Voon WC; Sheu SH; Lai WT
    Am J Cardiol; 2006 Mar; 97(5):646-50. PubMed ID: 16490430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure in treating hyperlipidemia.
    Meena AK; Ratnam DV; Chandraiah G; Ankola DD; Rao PR; Kumar MN
    Lipids; 2008 Mar; 43(3):231-41. PubMed ID: 18196308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of atorvastatin on pancreatic Beta-cell function and insulin resistance in type 2 diabetes mellitus patients: a randomized pilot study.
    Goyal A; Singh S; Tandon N; Gupta N; Gupta YK
    Can J Diabetes; 2014 Dec; 38(6):466-72. PubMed ID: 24933106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome.
    Van Rooyen DM; Gan LT; Yeh MM; Haigh WG; Larter CZ; Ioannou G; Teoh NC; Farrell GC
    J Hepatol; 2013 Jul; 59(1):144-52. PubMed ID: 23500152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice.
    Tahara A; Kurosaki E; Yokono M; Yamajuku D; Kihara R; Hayashizaki Y; Takasu T; Imamura M; Li Q; Tomiyama H; Kobayashi Y; Noda A; Sasamata M; Shibasaki M
    Eur J Pharmacol; 2013 Sep; 715(1-3):246-55. PubMed ID: 23707905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study between atorvastatin and losartan on high fat diet-induced type 2 diabetes mellitus in rats.
    Mourad AA; Heeba GH; Taye A; El-Moselhy MA
    Fundam Clin Pharmacol; 2013 Oct; 27(5):489-97. PubMed ID: 22712525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of lipid lowering effect and influence on platelet aggregation of atorvastatin and simvastatin in patients ischemic heart disease with type II diabetes and combined hyperlipidemia].
    Vasiutina EI; Metel'kaya VA; Akhmedzhanov NM; Raszzivin VA; Oganov RG
    Kardiologiia; 2003; 43(1):30-5. PubMed ID: 12913995
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients.
    Ceriello A; Assaloni R; Da Ros R; Maier A; Piconi L; Quagliaro L; Esposito K; Giugliano D
    Circulation; 2005 May; 111(19):2518-24. PubMed ID: 15867169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
    Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
    Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus.
    Riad A; Du J; Stiehl S; Westermann D; Mohr Z; Sobirey M; Doehner W; Adams V; Pauschinger M; Schultheiss HP; Tschöpe C
    Eur J Pharmacol; 2007 Aug; 569(3):204-11. PubMed ID: 17669395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "2-(4-Fluorobenzamido)-4-methylthiazole-5-carboxylic acid" a novel thiazole compound, ameliorates insulin sensitivity and hyperlipidaemia in streptozotocin-induced diabetic rats: Plausible role of inflammatory and oxidative stress markers.
    Paudel YN; Ali MR; Adil M; Bawa S; Sharma M
    Biomed Pharmacother; 2017 Nov; 95():1232-1241. PubMed ID: 28938514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers.
    Abdin AA; Baalash AA; Hamooda HE
    J Diabetes Complications; 2010; 24(3):168-78. PubMed ID: 19328014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.